financetom
Business
financetom
/
Business
/
Qualcomm forecasts quarterly revenue above estimates on smartphone strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Qualcomm forecasts quarterly revenue above estimates on smartphone strength
Jul 31, 2024 1:30 PM

(Reuters) - Qualcomm ( QCOM ) forecast fourth-quarter revenue above Wall Street estimates on Wednesday, helped by strong demand for high-end Android devices, and betting that more chips will be used in smartphones that are getting AI upgrades.

Shares of the San Diego, California-based chip firm rose more than 5% in extended trading. 

The addition of artificial intelligence (AI) capabilities to smartphones has driven a resurgence in end-market demand after the industry slumped to its lowest level in years, lifting orders for Qualcomm. 

The company forecast a revenue range with a midpoint of $9.9 billion for the fourth quarter, compared with analysts' average estimate of $9.71 billion, according to LSEG data. 

Increased demand from Chinese customers for premium and high-tier smartphones is driving orders for Qualcomm's ( QCOM ) chips in the country, CEO Cristiano Amon said in May. 

Added AI features have also led to smartphone providers using more of Qualcomm's ( QCOM ) semiconductors in their devices to help support the processing requirements of advanced functions. 

The biggest smartphone chips maker forecast an adjusted fourth-quarter earnings range with a midpoint of $2.55 per share, compared with estimates of $2.45. 

During the June quarter, Apple and Vivo, both Qualcomm ( QCOM ) customers, held top positions in the Chinese smartphone market, which grew 6% during that period, according to data from research firm Counterpoint. 

Analysts expect Apple to return to revenue growth when the iPhone maker reports results for its fiscal third quarter on Thursday.

In Qualcomm's ( QCOM ) chip segment, the company forecast fiscal fourth-quarter sales with a midpoint of $8.4 billion, compared with analysts' estimates of $8.33 billion, according to Visible Alpha.

The company forecast fourth-quarter patent-licensing sales with a midpoint of $1.45 billion, compared with Visible Alpha estimates of $1.37 billion.

Qualcomm ( QCOM ) reported third-quarter adjusted revenue of $9.39 billion, compared with estimates of $9.22 billion.

(Reporting by Arsheeya Bajwa in Bengaluru; Editing by Sriraj Kalluvila and Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OSI Systems Fiscal Q1 Earnings, Revenue Gain; Raises FY2025 Outlook
OSI Systems Fiscal Q1 Earnings, Revenue Gain; Raises FY2025 Outlook
Nov 2, 2024
09:04 AM EDT, 10/24/2024 (MT Newswires) -- OSI Systems ( OSIS ) shares were up 9% premarket Thursday after the company reported fiscal Q1 earnings and revenue that beat analysts' expectations and lifted its fiscal-year 2025 guidance. The electronic systems and components manufacturer reported fiscal Q1 adjusted earnings of $1.25 per diluted share, up from $0.91 a year earlier. Analysts...
Tractor Supply to Acquire Online Pet Pharmacy Allivet
Tractor Supply to Acquire Online Pet Pharmacy Allivet
Nov 2, 2024
09:03 AM EDT, 10/24/2024 (MT Newswires) -- Tractor Supply ( TSCO ) said Thursday it has agreed to acquire Allivet, a private online pet pharmacy. The acquisition will strengthen Tractor Supply's ( TSCO ) offerings for companion animals, equestrian and livestock customers while creating new growth opportunities. The company also said that the acquisition will provide a low-cost pharmacy service...
Merck Says European Commission Approves 2 New Indications for Keytruda
Merck Says European Commission Approves 2 New Indications for Keytruda
Nov 2, 2024
09:07 AM EDT, 10/24/2024 (MT Newswires) -- Merck ( MRK ) said Thursday its anti-PD-1 therapy Keytruda has received two new indications in gynecologic cancers from the European Commission. The approvals are for Keytruda in combination with carboplatin and paclitaxel, and in combination with chemoradiotherapy, the company said. The first approval is for the first-line treatment of primary advanced or...
Linde to De-Captivate Air Separation Units, Expand Industrial Gases Supply to Tata Steel
Linde to De-Captivate Air Separation Units, Expand Industrial Gases Supply to Tata Steel
Nov 2, 2024
09:12 AM EDT, 10/24/2024 (MT Newswires) -- Linde ( LIN ) said Thursday it signed agreements to de-captivate two air separation units and expand its existing supply of industrial gases to Tata Steel Limited's iron and steel making facility in India. Linde ( LIN ) said it is acquiring two additional ASUs, which are both under construction and expected to...
Copyright 2023-2025 - www.financetom.com All Rights Reserved